ClinicalTrialsFinder

Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma Clinical Trials in Madrid, Madrid

1 recruitingMadrid, Madrid, Spain

Showing 1–1 of 1 trials

Recruiting
Phase 2

Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.

Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello65 enrolled11 locationsNCT06856213